The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review
Multiple sclerosis (MS) is a chronic, inflammatory, degenerative demyelinating disease of the central nervous system (CNS) of unknown etiology that affects individuals in their early adulthood. In the last decade, life expectancy for people with MS (PwMS) has almost equaled that of the general popul...
Main Authors: | Viviana Nociti, Marina Romozzi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/13/11/1524 |
Similar Items
-
Multiple Sclerosis and Autoimmune Comorbidities
by: Viviana Nociti, et al.
Published: (2022-11-01) -
Update on Multiple Sclerosis Molecular Biomarkers to Monitor Treatment Effects
by: Viviana Nociti, et al.
Published: (2022-03-01) -
The Role of BDNF in Multiple Sclerosis Neuroinflammation
by: Viviana Nociti, et al.
Published: (2023-05-01) -
Prognostic value of the modified multiple myeloma comorbidity index in real clinical practice
by: N. V. Skvortsova, et al.
Published: (2020-10-01) -
Navigating choice in multiple sclerosis management
by: Ralf A. Linker, et al.
Published: (2019-02-01)